NK1, a natural splice variant of hepatocyte growth factor/scatter factor, is a partial agonist in vivo

Molecular and Cellular Biology

Volumn 18, Issue 3, 1998, Pages 1275-1283

  Jakubczak, John L ^a,b   Larochelle, William J ^a   Merlino, Glenn ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NOVARTIS PHARMA AG   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

GENE PRODUCT; SCATTER FACTOR; TYROSINE; TYROSINE KINASE RECEPTOR;

ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CONTROLLED STUDY; GENE; GENE EXPRESSION; IMMUNOHISTOCHEMISTRY; MORPHOGENESIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TRANSGENIC MOUSE;

EID: 0031911137     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.18.3.1275     Document Type: Article

References (42)

1. Bellusci, S., G. Moens, G. Gaudino, P. Comoglio, T. Nakamura, J. P. Thierey, and J. Jouanneau. 1994. Creation of an hepatocyte growth factor/ scatter factor autocrine loop in carcinoma cells induces invasive properties associated with increased tumorigenicity. Oncogene 9:1091-1099.
2. Bladt, T., D. Riethmacher, S. Isenmann, A. Aguzzi, and C. Birchmeier. 1995. Essential role for the c-met receptor in the migration of myogenic precursor cells into the limb bud. Nature 376:768-771.
3. Chan, A. M.-L., J. S. Rubin, D. P. Bottaro, D. W. Hirscfield, M. Chedid, and S. A. Aaronson. 1991. Identification of a competitive HGF antagonist encoded by an alternative transcript. Science 254:1382-1385.
4. Cioce, V., K. G. Csaky, A. M.-L. Chan, D. P. Bottaro, W. G. Taylor, R. Jensen, S. A. Aaronson, and J. S. Rubin. 1996. Hepatocyte growth factor (HGF)/NK1 is a naturally occurring HGF/scatter factor variant with partial agonist/antagonist activity. J. Biol. Chem. 271:13110-13115.
5. Di Renzo, M. F., R. Poulsom, M. Olivero, P. M. Comoglio, and N. R. Lemoine. 1995. Expression of the Met/hepatocyte growth factor receptor in human pancreatic cancer. Cancer Res. 55:1129-1138.
6. Ferracini, R., M. Olivero, M. F. Di Renzo, M. Martano, C. De Giovanni, P. Nanni, G. Basso, K. Scotlandi, P.-L. Lollini, and P. M. Comoglio. 1996. Retrogenic expression of the Met proto-oncogene correlates with the invasive phenotype of human rhabdomyosarcomas. Oncogene 11:1697-1705.
7. Halaban, R., J. S. Rubin, Y. Funasaka, M. Cobb, T. Boulton, D. Faletto, E. Rosen, A. Chan, K. Yoko, W. White, C. Cook, and G. Moellmann. 1992. Met and hepatocyte growth factor/scatter factor signal transduction in normal melanocytes and melanoma cells. Oncogene 7:2195-2206.
8. Hartmann, G., L. Naldini, K. M. Weidner, M. Sachs, E. Vigna, P. M. Comoglio, and W. Birchmeier. 1992. A functional domain in the heavy chain of scatter factor/hepatocyte growth factor binds the c-Met receptor and induces cell dissociation but no mitogenesis. Proc. Natl. Acad. Sci. USA 89:11574-11578.
9. Igawa, T., S. Kanda, H. Kanetake, Y. Saitoh, A. Ichihara, Y. Tomita, and T. Nakamura. 1991. Hepatocyte growth factor is a potent mitogen for cultured rabbit renal tubular epithelial cells. Biochem. Biophys. Res. Commun. 174:831-838.
10. Itakura, Y., T. Yamamoto, K. Matsumoto, and T. Nakamura. 1994. Autocrine stimulation of motility in SBC-5 human lung carcinoma cells by a two-kringle variant of HGF. Cancer Lett. 83:235-243.
11. Jeffers, M., S. Rong, and G. F. Vande Woude. 1996. Hepatocyte growth factor/scatter factor Met signaling in tumorigenicity and invasion/metastasis. J. Mol. Med. 74:505-513.
12. Jhappan, C., C. Stahle, R. N. Harkins, N. Fausto, G. H. Smith, and G. T. Merlino. 1990. TGFa overexpression in transgenic mice induces liver neoplasia and abnormal development of the mammary gland and pancreas. Cell 61:1137-1146.
13. Lamszus, K., A. Joseph, L. Jin, Y. Yao, S. Chowdhury, A. Fuchs, P. J. Polvrini, I. D. Goldberg, and E. M. Rosen. 1996. Scatter factor binds to thrombospondin and other extracellular matrix components. Am. J. Pathol. 149:805-819.
14. Liu, Y., G. K. Michalopoulos, and R. Zarnegar. 1993. Molecular cloning and characterization of cDNA encoding mouse hepatocyte growth factor. Biochim. Biophys. Acta 1216:299-303.
15. Lokker, N. A., and P. J. Godowski. 1993. Generation and characterization of a competitive antagonist of human hepatocyte growth factor, HGF/NK1. J. Biol. Chem. 268:17145-17150.
16. Matsumoto, K., and T. Nakamura. 1996. Emerging multipotent aspects of hepatocyte growth factor. J. Biochem. 119:591-600.
17. Matsumoto, K., and T. Nakamura. 1995. Hepatocyte growth factor, p. 450-474. In M. Goligorsky (ed.), Acute renal failure: new concepts and therapeutic strategies. Churchill Livingstone, New York, N.Y.
18. Miyazawa, K., A. Kitamura, D. Naka, and N. Kitamura. 1991. An alternatively processed mRNA generated from human hepatocyte growth factor gene. Eur. J. Biochem. 197:15-22.
19. Natali, P. G., M. R. Nicotra, M. F. Di Renzo, M. Prat, A. Bigotti, R. Cavaliere, and P. M. Comoglio. 1993. Expression of the c-met/HGF receptor in human melanocytic neoplasms: demonstration of the relationship to malignant melanoma tumour progression. Br. J. Cancer 68:746-750.
20. Niranjan, B., L. Buluwela, J. Yant, N. Perusinghe, A. Atherton, D. Phippard, T. Dale, B. Gusterson, and T. Kamalati. 1995. HGF/SF: a potent cytokine for mammary growth, morphogenesis and development. Development 121:2897-2908.
21. Palmiter, R. D., E. P. Sandgren, D. M. Koeller, and R. L. Brinster. 1993. Distal regulatory elements from the mouse metallothionein locus stimulate gene expression in transgenic mice. Molo. Cell. Biol. 13:5266-5275.
22. Prat, M., R. P. Narsimhan, T. Crepaldi, M. R. Nicotra, P. G. Natali, and P. M. Comoglio. 1991. The receptor encoded by the human c-MET oncogene is expressed in hepatocytes, epithelial cells and solid tumors. Int. J. Cancer 49:323-328.
23. Rahimi, N., E. Tremblay, L. McAdam, M. Park, R. Schwall, and B. Elliott. 1996. Identification of a hepatocyte growth factor autocrine loop in a murine mammary carcinoma. Cell Growth Differ. 7:263-270.
24. Rong, S., L. A. Donehower, M. F. Hansen, L. Strong, M. Tainsky, M. Jeffers, J. H. Resau, E. Hudson, I. Tsarfaty, and G. F. Vande Woude. 1995. Met proto-oncogene product is overexpressed in tumors of p53-deficient mice and tumors of Li-Fraumeni patients. Cancer Res. 55:1963-1970.
25. Rong, S., M. Jeffers, J. H. Resau, I. Tsarfaty, M. Oskarsson, and G. F. Vande Woude. 1993. Met expression and sarcoma tumorigenicity. Cancer Res. 53:5355-5360.
26. Sakata, H., S. J. Stahl, W. G. Taylor, J. M. Rosenberg, K. Sakaguchi, P. T. Wingfield, and J. S. Rubin. 1997. Heparin binding and oligomerization of hepatocyte growth factor/scatter factor isoforms. J. Biol. Chem. 272:9457-9463.
27. Sakata, H., H. Takayama, R. Sharp, J. S. Rubin, G. Merlino, and W. J. LaRochelle. 1996. Hepatocyte growth factor/scatter factor overexpression induces growth, abnormal development, and tumor formation in transgenic mouse livers. Cell Growth Differ. 7:1513-1523.
28. Schmidt, C., F. Bladt, S. Goedecke, V. Brinkmann, W. Zschiesche, M. Sharpe, E. Gherardi, and C. Birchmeier. 1995. Scatter factor/hepatocyte growth factor is essential for liver development. Nature 373:699-702.
29. Schmidt, L., F.-M. Duh, F. Chen, T. Kishida, G. Glenn, P. Choyke, S. W. Scherer, Z. Zhuang, I. Lubensky, M. Dean, R. Allikmets, A. Chidambaram, U. R. Bergerheim, J. T. Feltis, C. Casadevall, A. Zamarron, M. Bernues, S. Richard, C. J. M. Lips, M. M. Walther, L.-C. Tsui, L. Geil, M. L. Orcutt, T. Stackhouse, J. Lipan, L. Slife, H. Brauch, J. Decker, G. Niehans, M. D. Hughson, H. Moch, S. Storkel, M. I. Lerman, W. M. Linehan, and B. Zbar. 1997. Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas. Nat. Genet. 16:68-73.
30. Schwall, R. H., L. Y. Chang, P. J. Godowski, D. W. Kahn, K. J. Hillan, K. D. Bauer, and T. F. Zioncheck. 1996. Heparin induces dimerization and confers proliferative activity onto the hepatocyte growth factor antagonists NK1 and NK2. J. Cell Biol. 133:709-718.
31. Sonnenberg, E., D. Meyer, K. M. Weidner, and C. Birchmeier. 1993. Scatter factor/hepatocyte growth factor and its receptor, the c-met tyrosine kinase, can mediate a signal exchange between mesenchyme and epithelia during mouse development. J. Cell Biol. 123:223-235.
32. Tajima, H., K. Matsumoto, and T. Nakamura. 1991. Hepatocyte growth factor has potent anti-proliferative activity in various tumor cell lines. FEBS Lett. 291:229-232.
33. Takayama, H., W. J. LaRochelle, R. Sharp, T. Otsuka, P. Kriebel, M. Anver, S. A. Aaronson, and G. Merlino. 1997. Diverse tumorigenesis associated with aberrant development in mice overexpressing hepatocyte growth factor/scatter factor. Proc. Natl. Acad. Sci. USA 94:701-706.
34. Takayama, H., W. J. LaRochelle, S. G. Sabnis, T. Otsuka, and G. Merlino. 1997. Renal tubular hyperplasia, polycystic disease and glomerulosclerosis in transgenic mice overexpressing hepatocyte growth factor/scatter factor. Lab. Investig. 77:131-138.
35. Takayama, H., W. J. LaRochelle, M. Anver, D. E. Bookman, and G. Merlino. 1996. Scatter factor/hepatocyte growth factor as a regulator of skeletal muscle and neural crest development. Proc. Natl. Acad. Sci. USA 93:5866-5871.
36. Tsarfaty, I., S. Rong, J. H. Resau, S. Rulong, P. P. da Silva, and G. F. Vande Woude. 1994. The Met proto-oncogene mesenchymal to epithelial cell conversion. Science 263:98-101.
37. Tuck, A. B., M. Park, E. E. Sterns, A. Boag, and B. E. Elliott. 1996. Coexpression of hepatocyte growth factor and receptor (Met) in human breast carcinoma. Am. J. Pathol. 148:225-232.
38. Uehara, Y., O. Minowa, C. Mori, K. Shiota, J. Kuno, T. Noda, and N. Kitamura. 1995. Placental defect and embryonic lethality in mice lacking hepatocyte growth factor/scatter factor. Nature 373:702-705.
39. Vigna, E., L. Naldini, L. Tamagnone, P. Longati, A. Bardelli, F. Maina, C. Ponzetto, and P. M. Comoglio. 1994. Hepatocyte growth factor and its receptor, the tyrosine kinase encoded by the c-MET proto-oncogene. Cell. Mol. Biol. (Noisy-le-Grand) 40:597-604.
40. Woolf, A. S., M. Kolatsi-Joannou, P. Hardman, E. Andermarcher, C. Moorby, L. G. Fine, P. S. Jat, M. D. Noble, and E. Gherardi. 1995. Roles of hepatocyte growth factor/scatter factor and the Met receptor in the early development of the metanephros. J. Cell Biol. 128:171-184.
41. Yamashita, J., M. Ogawa, S. Yamashita, K. Nomura, M. Kuramoto, T. Saishoji, and S. Shin. 1994. Immunoreactive hepatocyte growth factor is a strong and independent predictor of recurrence and survival in human breast cancer. Cancer Res. 54:1630-1633.
42. Zarnegar, R., and G. K. Michalopoulos. 1995. The many faces of hepatocyte growth factor: from hepatopoiesis to hematopoiesis. J. Cell Biol. 129:1177-1180.